Profile for Poland Patent: 3172209
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Poland Patent: 3172209
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 10,596,178 | Jul 22, 2035 | Novartis Pharm | TABRECTA | capmatinib hydrochloride |
| 12,208,101 | Jul 22, 2035 | Novartis Pharm | TABRECTA | capmatinib hydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
